Identification of Flavonoids from Scutellaria barbata D. Don as Inhibitors of HIV-1 and Cathepsin L Proteases and Their Structure–Activity Relationships
-
Published:2023-05-31
Issue:11
Volume:28
Page:4476
-
ISSN:1420-3049
-
Container-title:Molecules
-
language:en
-
Short-container-title:Molecules
Author:
Tang Ting-Ting1, Li Su-Mei2ORCID, Pan Bo-Wen1, Xiao Jun-Wei1, Pang Yu-Xin1, Xie Shou-Xia2, Zhou Ying1, Yang Jian3, Wei Ying1
Affiliation:
1. College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China 2. Department of Pharmacology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, China 3. College of Pharmacy and Nutrition, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada
Abstract
Scutellaria barbata D. Don (SB, Chinese: Ban Zhi Lian), a well-known medicinal plant used in traditional Chinese medicine, is rich in flavonoids. It possesses antitumor, anti-inflammatory, and antiviral activities. In this study, we evaluated the inhibitory activities of SB extracts and its active components against HIV-1 protease (HIV-1 PR) and SARS-CoV2 viral cathepsin L protease (Cat L PR). UPLC/HRMS was used to identify and quantify the major active flavonoids in different SB extracts, and fluorescence resonance energy transfer (FRET) assays were used to determine HIV-1 PR and Cat L PR inhibitions and identify structure–activity relationships. Molecular docking was also performed, to explore the diversification in bonding patterns of the active flavonoids upon binding to the two PRs. Three SB extracts (SBW, SB30, and SB60) and nine flavonoids inhibited HIV-1 PR with an IC50 range from 0.006 to 0.83 mg/mL. Six of the flavonoids showed 10~37.6% inhibition of Cat L PR at a concentration of 0.1 mg/mL. The results showed that the introduction of the 4′-hydroxyl and 6-hydroxyl/methoxy groups was essential in the 5,6,7-trihydroxyl and 5,7,4′-trihydroxyl flavones, respectively, to enhance their dual anti-PR activities. Hence, the 5,6,7,4′-tetrahydroxyl flavone scutellarein (HIV-1 PR, IC50 = 0.068 mg/mL; Cat L PR, IC50 = 0.43 mg/mL) may serve as a lead compound to develop more effective dual protease inhibitors. The 5,7,3′,4′-tetrahydroxyl flavone luteolin also showed a potent and selective inhibition of HIV-1 PR (IC50 = 0.039 mg/mL).
Funder
Innovation Group Project of Guizhou Province Guizhou Provincial Science and Technology Projects Research Center of Molecular Bioactivity from Traditional Chinese Medicine and Ethnomedicine Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties the Youth Science and Technology Talent Growth Project of Guizhou Province the Project of Guizhou Provincial Health Commission
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference24 articles.
1. (2023, May 17). WHO: Coronavirus Disease 2019 (COVID-19): Situation Report: COVID-19 Partners Platform. Available online: https://covid19.who.int/. 2. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus;Raman;Eur. Heart J.,2022 3. Secondary attack rate and super spreading events for SARS-CoV-2;Liu;Lancet,2020 4. Li, G.D., Hilgenfeld, R., Whitley, R., and Clercq, E.D. (2023, May 25). Therapeutic Strategies for COVID-19: Progress and Lessons Learned, Nature Reviews Drug Discovery. Available online: https://doi.org/10.1038/s41573-023-00672-y. 5. Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV/AIDS;Ghosh;J. Med. Chem.,2016
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|